Photoinduced Fluorescence Activation and Nitric Oxide Release with Biocompatible Polymer Nanoparticles

A viable strategy to encapsulate a fluorophore/photochrome dyad and a nitric oxide photodonor within supramolecular assemblies of a cyclodextrin‐based polymer in water was developed. The two photoresponsive guests do not interact with each other within their supramolecular container and can be operated in parallel under optical control. Specifically, the dyad permits the reversible switching of fluorescence on a microsecond timescale for hundreds of cycles, and the photodonor enables the irreversible release of nitric oxide. Furthermore, these supramolecular assemblies cross the membrane of human melanoma cancer cells and transport their cargo in the cytosol. The fluorescence of one component allows the visualization of the labeled cells, and its switchable character could, in principle, be used to acquire super‐resolution images, while the release of nitric oxide from the other induces significant cell mortality. Thus, our design logic for the construction of biocompatible nanoparticles with dual functionality might evolve into the realization of valuable photoresponsive probes for imaging and therapeutic applications.     

一氧化氮合酶的结构及其催化机理

综述了一氧化氮合酶的结构、功能和催化路径, 讨论了诱导型一氧化氮合酶的结构和功能的关系以及加氧氧化的机理.     

新型微盘传感器的研制及用于单细胞释放NO监测

首次提出了一种新型碳纳米管修饰方法, 采用精确的空间操纵, 在碳纤维微盘电极盘面上修饰单壁碳纳米管, 得到新型高灵敏的NO微盘传感器, 与未修饰电极相比, 灵敏度提高10倍, NO检出限达到4.3 nmol/L, 已被成功地应用于实时动态监测单个人脐静脉内皮细胞中NO的释放.     

Dissolution Mechanism of UO2 in Nitric Acid Solution by Photochemical Reaction

Photodissolution tests of UO₂ sintered pellets were carried out in 3M nitric acid solution and at about 50 °C under UV irradiation. The light source was a Hg-lamp emitting a light of 254nm wavelength. In the products, chemicals such as H₂O₂ and NO₂ ^– ion were detected during photodissolution of the UO₂ sintered pellets. Based on this result, a new dissolution mechanism of UO₂ in nitric acid solution by photochemical reaction was suggested in this study.     

Light-Triggered Nitric Oxide Release by a Photosensitizer to Combat Bacterial Biofilm Infections

Bacterial biofilms are a serious global health concern, often responsible for persistent infections. New strategies to prevent and treat bacterial infections by eradication of the biofilms are urgently needed. A novel ruthenium-based compound is reported in this study that functions as both a boronic acid-decorated photosensitizer (PS) and a light-triggered nitric oxide (NO) releasing agent. The compound can selectively attach to the bacterial membrane and biofilms and it is highly potent at eradicating Pseudomonas aeruginosa biofilms through the simultaneous release of NO and reactive oxygen species (ROS). The compound, which is more effective than clinical antibiotic tobramycin, also has excellent bacterial specificity and shows no significant cytotoxicity to human cells. The results reveal potential applications of this innovative dual-functional photoactivated ruthenium compound to combat bacterial biofilm infections.     

Nitric Oxide Release for Enhanced Biocompatibility and Analytical Performance of Implantable Electrochemical Sensors

The real-time, continuous monitoring of glucose/lactate, blood gases and electrolytes by implantable electrochemical sensors holds significant value for critically ill and diabetic patients. However, the wide-spread use of such devices has been seriously hampered by implant-initiated host responses (e. g., thrombus formation, inflammatory responses and bacterial infection) when sensors are implanted in blood or tissue. As a result, the accuracy and usable lifetime of in vivo sensors are often compromised. Nitric oxide (NO) is an endogenous gas molecule able to inhibit platelet adhesion/activation, inflammatory responses and bacterial growth. As such, the release of NO from the surfaces of in vivo sensors is a promising strategy for enhancement of their biocompatibility and analytical performance. In this review, the physiological functions of NO to improve the biocompatibility of implantable electrochemical sensors are introduced, followed by a brief analysis of chemical approaches to realize NO release from such devices. A detailed summary of the various types of NO releasing electrochemical sensors reported to date and their performance in benchtop and/or in vivo testing are also provided. Finally, the prospects of future developments to further advance NO releasing sensor technology for clinical use are discussed.     

Photochemical Processes Involving Graphene Oxide

Theoretical and Experimental Chemistry - Recent research on photochemical processes involving graphene oxide are summarized and analyzed. Such processes include the reduction of this oxide upon...     

罗丹明B聚合物修饰单壁碳纳米管薄膜电极的制备、表征及一氧化氮活体分析应用

以单壁碳纳米管作为电极材料,基于减压过滤和电聚合方法制备了一种薄膜型一氧化氮(NO)电化学传感器。扫描电镜、红外光谱和电化学交流阻抗表征表明,减压过滤可以制备出导电性好、电分析性能优良的薄膜电极,而罗丹明B能通过电聚合在其表面形成高比表面的纳米敏感结构。这种薄膜型电化学传感器对NO具有灵敏的电化学响应,其安培氧化电流与NO浓度在7.2×10-8~2.5×10-5mol/L范围内呈良好的线性关系,检出限(S/N=3)达3.6×10-8mol/L。将该传感器紧贴在麻醉豚鼠的肝脏表面,成功实现了肝组织细胞在L-精氨酸刺激下NO释放的实时监测。     

Mechanism of Nitric Oxide Synthase Regulation: Electron Transfer and Interdomain Interactions

Nitric oxide synthase (NOS), a flavo-hemoprotein, tightly regulates nitric oxide (NO) synthesis and thereby its dual biological activities as a key signaling molecule for vasodilatation and neurotransmission at low concentrations, and also as a defensive cytotoxin at higher concentrations. Three NOS isoforms, iNOS, eNOS and nNOS (inducible, endothelial, and neuronal NOS), achieve their key biological functions by tight regulation of interdomain electron transfer (IET) process via interdomain interactions. In particular, the FMN-heme IET is essential in coupling electron transfer in the reductase domain with NO synthesis in the heme domain by delivery of electrons required for O(2) activation at the catalytic heme site. Compelling evidence indicates that calmodulin (CaM) activates NO synthesis in eNOS and nNOS through a conformational change of the FMN domain from its shielded electron-accepting (input) state to a new electron-donating (output) state, and that CaM is also required for proper alignment of the domains. Another exciting recent development in NOS enzymology is the discovery of importance of the the FMN domain motions in modulating reactivity and structure of the catalytic heme active site (in addition to the primary role of controlling the IET processes). In the absence of a structure of full-length NOS, an integrated approach of spectroscopic (e.g. pulsed EPR, MCD, resonance Raman), rapid kinetics (laser flash photolysis and stopped flow) and mutagenesis methods is critical to unravel the molecular details of the interdomain FMN/heme interactions. This is to investigate the roles of dynamic conformational changes of the FMN domain and the docking between the primary functional FMN and heme domains in regulating NOS activity. The recent developments in understanding of mechanisms of the NOS regulation that are driven by the combined approach are the focuses of this review. An improved understanding of the role of interdomain FMN/heme interaction and CaM binding may serve as the basis for the design of new selective inhibitors of NOS isoforms.     

Asymmetric Anion‐selective Membrane Electrode for Determining Nitric Oxide Release Rates from Ppolymeric Films/Electrochemical Devices

A novel potentiometric method for the determination of nitric oxide (NO) is presented. The assessment of NO levels is based on the rapid reaction of NO with oxyhemoglobin, during which nitrate is formed and then detected potentiometrically using a polymeric membrane anion‐selective electrode. The composition of the anion‐selective membrane is optimized to eliminate the response to high levels of oxyhemoglobin reagent used to react with NO to form NO₃^?. The practical utility of the method is demonstrated by determining the NO release rates from NO donor‐doped polymeric films, as well as from a new electrochemical NO generation system within the range of 10 to 55×10^?10 mol ? min^?1. The values measured with the new assay system are shown to correlate well with a chemiluminescence reference method after accounting for the trapping efficiency of NO by the oxyhemoglobin solution.     

甲氨蝶呤与一氧化氮供体或一氧化氮合酶抑制剂组合物的合成

一氧化氮(nitric oxide,NO)在肿瘤病理生理过程中产生多方面的生化作用,诸如引起的某些核苷酸碱基的羟基化,参与免疫系统清除肿瘤细胞,促进肿瘤细胞凋亡和调节血管生成等．在此基础上,首次提出将NO供体(NO donor)或一氧化氮合酶(nitric oxide synthase,NOS)抑制剂分别连接到甲氨蝶呤(methotrexate,MTX,MTX本身就是NOS抑制剂)的α或γ位羧基上的设想,设计并合成出：(1)MTX-NO供体(3-羟甲基-4-苯基-1,2,5-噁二唑-2-氧化物,属于Furoxan衍生物,缩写为FU)：1a(MTX-α-FU),2a(MTX-γ-FU);(2)MTX-NOS抑制剂(L-N^ω-硝基精氨酸或L-N^ω-硝基精氨酸甲酯)：1b(MTX-α-L-N^ω-NO2-Arg),2b(MTX-γ-L-N^ω-NO2-Arg),1c(MTX-α-L-N^ω-NO2-Arg-OMe),2c(MTX-γ-L-N^ω-NO2-Arg-OMe)．在生物活性测试中,我们选择耐MTX细胞株K-562(慢性粒细胞性白血病急性病变细胞株),进行抗肿瘤活性测试,得到以下结果：(1)脂溶性差的MTX衍生物1b,2b抗肿瘤活性低于MTX,其它1a,2a;1c,2c均优于MTX;(2)连接有NO供体的MTX明显增强了MTX衍生物的抗肿瘤活性;(3)MTX中谷氨酸γ位组合物抗肿瘤活性均高于相应的α位异构体的活性．以上初步结果,将对进一步研究NO抗肿瘤作用以及新的抗肿瘤药物设计提供新的思路,对肿瘤临床化疗也有一定的参考价值．     

PVP/Pd/IrO_2/Nafion修饰微电极用于成纤维细胞中一氧化氮释放的研究

采用PVP/Pd/IrO_2/Nafion修饰电极对成纤维细胞中NO的释放情况进行了研究 。结果表明,在正常状态下,采用NO前体L-精氨酸和乙酰胆碱对成纤维细胞进行刺 激后没有NO的释放;当用脂多糖进行诱导后,则释放出高浓度的NO,加入L-精氨酸 和乙酰胆碱都促进了NO的合成,而L-NNA的加入则逆转了L-精氨酸和乙酰胆碱的作 用。     

Standard Mixtures of Nitric Oxide

Abstract

Standard mixtures of nitric oxide may be prepared by converting NO₂ to NO in presence of a molybdenum catalyst. Quantitative conversion has been obtained in the concentration range 0–100 pnm at temperatures as low as 200°C.

It has been proved that this material is scarcely affected by poisoning when exposed to high levels of nitrogen oxides.     

Electrochemical Investigation of the Role of Reducing Agents in Copper‐Catalyzed Nitric Oxide Release from S‐Nitrosoglutathione

Studies of nitric oxide (NO) release from S‐nitrosoglutathione (GSNO) decomposition by Cu²⁺ in the presence of reducing agents were performed using a nickel porphyrin and Nafion‐coated microsensor in order to compare the efficiency of sodium hydrosulfite (Na₂S₂O₄) and sodium borohydride (NaBH₄) to that of the most abundant endogenous reducer, glutathione (GSH). When it was mixed to Cu(NO₃)₂ and added to equimolar concentration of GSNO, each reducing agent caused a NO release (measured in terms of oxidation current) but only NaBH₄ induced a proportional rise if its concentration doubled and that of Cu²⁺ remained constant. For Na₂S₂O₄, there was a mild increase and for GSH, no change. Furthermore, when Cu²⁺ concentrations ranging from 0.5 to 5 μM were mixed with 2 μM reducing agent and added to 2 μM GSNO_, the NO oxidation current linearly increased with NaBH₄ and was constant with Na₂S₂O₄. Concerning GSH, Cu²⁺ dose‐dependently increased the NO release from GSNO only if the Cu²⁺‐to‐reducer ratio was ≤1. However, GSH formed the catalytic species Cu⁺ even in excess of Cu²⁺ and GSNO as indicated by suppression of the Cu²⁺/GSH‐induced NO release when the Cu⁺ chelator neocuproine was added to GSNO. This work shows that, among the 3 reducing agents, only NaBH₄ allows Cu²⁺ to dose‐dependently increase the NO release from GSNO for Cu²⁺‐to‐reducer ratios ranging from 0.25 to 2.5. Despite this good effectiveness, excess of NaBH₄ compared to both Cu²⁺ and GSNO seems to be required for optimal NO release.     

The Application of Nitric Oxide for Ocular Hypertension Treatment

Despite of various therapeutic methods for treating ocular hypertension and glaucoma, it still remains the leading cause of irreversible blindness. Intraocular pressure (IOP) lowering is the most effective way to slow disease progression and prevent blindness. Among the ocular hypotensive drugs currently in use, only a couple act on the conventional outflow system, which is the main pathway for aqueous humor outflow and the major lesion site resulting in ocular hypertension. Nitric oxide (NO) is a commendable new class of glaucoma drugs that acts on the conventional outflow pathway. An increasing number of nitric oxide donors have been developed for glaucoma and ocular hypertension treatment. Here, we will review how NO lowers IOP and the types of nitric oxide donors that have been developed. And a brief analysis of the advantages and challenges associated with the application will be made. The literature used in this review is based on Pubmed database search using ‘nitric oxide’ and ‘glaucoma’ as key words.     

一氧化氮化学性质的研究进展

概括了由Louis J. Ignarro, Ferid Murad和Robert F. Furchgott三位诺贝尔奖获得者提出的一氧化氮作为血管内皮松弛因子(EDRF)的作用机制及生物学意义; 同时也总结了100多年来一氧化氮在化学本质的探讨方面做出的研究成就; 归纳了一氧化氮自由基在化学反应过程中的行为本质.     

Analysis of Nitric Oxide from Chemical Donors Using CMOS Platinum Microelectrodes

Electrochemical detection of NO generated from chemical donors is reported. Because NO is an important biological messenger, many donor sources and detection methods have been developed. Few reports have characterized NO donors using electrochemistry despite electrochemical techniques being sensitive and selective. Here, a CMOS platinum microelectrode array is interfaced with a microfluidic device for the electrochemical analysis of NO from (Z)‐1‐[N‐(2‐aminoethyl)‐N‐(2‐ammonioethyl)amino]diazen‐1‐ium‐1,2‐diolate (DETA/NO). The donor parent amine fouls the electrode, resulting in substantial signal loss, but an electrochemical cleaning method was developed that substantially reduces fouling and allows detection of NO between 90 nM and 1 µM.     

一氧化氮神奇生物化学作用正在揭示中

95年夏天在北京举行的第27届国际化学奥林匹克有一道以NO的生物化学功能为主题的竞赛试题。反映了试题编制者们力求的先进性、趣味性和新颖性,受到广泛欢迎。下面是有关这个曾被美国某杂忑选为明星分子的小小无机分子神奇功能的一些新近报道的综述。读者通过阅读本文也许还可以感受到,化学对生命的研究已经进步到什么地步。